TOL Revolutionary Treatment for Advanced Cancer

TOL operates at the cellular level on cancers (most cancers, mesothelioma) that overexpress sodium channels and pumps. We can block sodium pumps and sodium outflow using a cardiac glycoside. Then we electrically stimulate to open Voltage Gated Sodium Channels (VGSC), letting sodium into the cell. Because advanced cancer cells overexpress sodium channels by 10-50 times compared to normal tissue, normal cells take in less sodium, less water, and their compliant membranes let them swell but not rupture; when the drug wears off they return to normal. Cancer cells take in much more sodium, much more water, and explode.